Poor Results with Technetium-99m (V) DMS and Iodine-131 MIBG in the Imaging of Medullary Thyroid Carcinoma

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 1986 Jul 1

PMID 3014086

Citations 9

Authors

T E Hilditch

J M Connell

A T Elliot

T Murray

N S Reed

Affiliations

Soon will be listed here.

Abstract

The value of [99mTc(V)]DMS and [131I]MIBG in imaging medullary carcinoma of the thyroid was investigated in five patients. Results with [99mTc(V)]DMS were negative in all five patients as well as with [131I]MIBG in four patients; however, there was significant tumor uptake in one patient with [131I]MIBG.

Citing Articles

Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.

Czepczynski R, Parisella M, Kosowicz J, Mikolajczak R, Ziemnicka K, Gryczynska M Eur J Nucl Med Mol Imaging. 2007; 34(10):1635-45.

PMID: 17530247 DOI: 10.1007/s00259-007-0479-1.

Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.

Magnani P, Paganelli G, Songini C, Samuel A, Sudati F, Siccardi A Br J Cancer. 1996; 74(5):825-31.

PMID: 8795589 PMC: 2074693. DOI: 10.1038/bjc.1996.443.

Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.

Koizumi M, Watari T, Hirabayashi K Ann Nucl Med. 1993; 7(1):53-6.

PMID: 8461239 DOI: 10.1007/BF03164793.

Medullary thyroid carcinoma mimicking an autonomous functioning nodule.

Rivas I, Gutierrez C, Vendrell J, Razkin S, Richart C J Endocrinol Invest. 1995; 18(3):224-7.

PMID: 7615909 DOI: 10.1007/BF03347806.

Thyroid uptake of MIBG in Sipple's syndrome.

Perdrisot R, Rohmer V, Lejeune J, Bigorgne J, Jallet P Eur J Nucl Med. 1988; 14(1):37-8.

PMID: 2898364 DOI: 10.1007/BF00252616.